Major side effects occur after coronary syndrome

Published Date: 13 Mar 2023

OSA itself predicted the incidence of MACCE in non-obese patients.

Read Full News

Latest News

Drug-Coated Balloons Match Stents for Coronary Lesions

A stent-free approach using drug-coated balloons shows comparable safety and efficacy to drug-eluting stents in treating new coronary artery lesions, a meta-analysis finds.

Advanced Dialysis Modality Can Affect Cardiac Biomarkers

Concentrations of cardiac biomarkers, including troponin I, troponin T, and NT-proBNP, are significantly reduced in asymptomatic patients undergoing haemodiafiltration, a recent trial finds.

Infertility Treatment Use Rises in US but Disparities Remain

Infertility treatment use among US birthing individuals has climbed from 2011 to 2022, fueled by assisted reproductive technology, yet stark racial, socioeconomic, and geographic gaps remain.

Lifestyle Changes May Slow Brain Aging Before Age 70

A structured multidomain lifestyle intervention slows increases in free water, an early MRI marker of white matter injury, in adults younger than 70 years at risk for cognitive decline.

Manufacturers Report $2.6B in Open Payments to Physicians

A new analysis finds that drug and device manufacturers paid billions to physicians last year, yet thousands of records did not identify the affiliated product.

Vascular Disease Linked to Parkinson's Disease Risk

Women with a history of heart or cerebrovascular disease face a markedly elevated risk for Parkinson's disease in a study.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Latest News

A stent-free approach using drug-coated balloons shows comparable safety and efficacy to drug-eluting stents in treating new coronary artery lesions, a meta-analysis finds.

Concentrations of cardiac biomarkers, including troponin I, troponin T, and NT-proBNP, are significantly reduced in asymptomatic patients undergoing haemodiafiltration, a recent trial finds.

Infertility treatment use among US birthing individuals has climbed from 2011 to 2022, fueled by assisted reproductive technology, yet stark racial, socioeconomic, and geographic gaps remain.

A structured multidomain lifestyle intervention slows increases in free water, an early MRI marker of white matter injury, in adults younger than 70 years at risk for cognitive decline.

A new analysis finds that drug and device manufacturers paid billions to physicians last year, yet thousands of records did not identify the affiliated product.

Women with a history of heart or cerebrovascular disease face a markedly elevated risk for Parkinson's disease in a study.

News All Time

A Shooter Opens Fire at Tourists and a Doctor Must Step In

A doctor and paramedic husband scramble to help the wounded when a mass shooter opens fire atop a historical pyramid in Mexico.

No One Workout Beats Every Metabolic Risk

A network meta analysis of 53 trials finds that no single exercise modality improves all components of metabolic syndrome, supporting phenotype tailored prescriptions.

Ex-Mayo AI Exec Sues, Says She Was Fired for Whistleblowing

The lawsuit highlights the oversight role medical institutions play in determining whether AI tools are safe and appropriate for patient care and research.

Early TAVI Cost-Effective in Asymptomatic Aortic Stenosis

Early transcatheter aortic valve implantation is projected to reduce healthcare costs and improve outcomes compared with watchful waiting in patients with asymptomatic severe aortic stenosis.

Patients With Seizures Face Higher Cardiovascular Risk

Patients with late-onset seizures have a higher risk for major ischaemic cardiovascular disease or death than those without seizures.

FDA Expert Panel Backs Compounding of Six Peptides

If the agency follows the committee’s advice, it will issue a rule that would allow the compounds to be sold for any condition.

New Inclisiran Therapy Shows Reduction in LDL Cholesterol

New lipid-lowering therapy, administered subcutaneously just twice a year, offers significant and sustained reduction of LDL-C across a diverse group of patient populations.

The Endless (and Maddening) Quest to Make a Good Biosensor

Why is it so hard to create a reliable biosensor? The concurrent stories of several researchers — decades in the making — may at last be reaching their final acts.

Infantile Hemangiomas: When Is a PHACE Workup Warranted?

Most congenital hemangiomas on the skin are managed with standard therapies, but an expert specified lesions that are at risk for systemic complications to provide guidance for rapid intervention.

ACE Inhibitors vs ARBs: Long-Term Cancer Risk Varies

A 23-year analysis of hypertensive patients reveals differing cancer incidence patterns between two widely prescribed blood pressure medication classes, with variations across specific malignancies.

Steroid Abuse Tied to Subtle Breathing Changes During Sleep

Androgen abuse in men is associated with modest changes in sleep-disordered breathing indices; however, sleep architecture remains largely preserved, and perceived sleep quality is unaffected.

How Declining Renal Health Shapes Heart Failure

Chronic kidney disease increases the likelihood of new-onset heart failure, with the strongest association seen for heart failure with preserved ejection fraction as kidney disease advances.

Childhood Obesity May Shape Lifelong Metabolic Health

Followed over decades, a cohort of children with faster BMI accumulation was more likely to develop clusters of metabolic diseases in adulthood, with the highest risk found in men.

Tafamidis Generic Wins EU Backing for ATTR Cardiomyopathy

Tafamidis Accord, a generic of Vyndaqel, could widen treatment availability for adults with hereditary transthyretin amyloidosis with cardiomyopathy.

Cardioband Scrutiny Widens Across European Hospitals

Hospitals in Germany and Switzerland are reexamining Cardioband use as questions grow over outcomes, safety monitoring, and how complex valve cases were selected.

New FIFA Decision Aids Guide Players During, After Pregnancy

New decision aids from FIFA help players decide with their doctors how to continue playing safely during pregnancy and postpartum.

Recommended News For You

Long-term study links chronic conditions in midlife to higher cancer risk and mortality

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

In inflammatory breast cancer, ER beta regulates estrogen signaling.

New Nanoparticles Can Destroy Undruggable Cancer Proteins

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?

EHA: European Hematology Association

Recommended Articles For You

Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies 

Exploring the Latest Advances in PTLD Cancer Treatment 

Modern Standards in Oncology and Patient Outcomes 

Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Never in a million years did I think I'd have to limit my chemotherapy.

2.

Report provides global picture of wide inequalities in care for women's cancers

3.

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

4.

Increased Exercise May Lower the Risk of Prostate Cancer.

5.

A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.

1.

The Pros and Cons of Steroid Therapy for ITP

2.

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates

3.

The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies

4.

Functional Iron Reserve Screening Before Clinical Deficiency: Clinical Insights and Evidence-Based Strategies

5.

Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

2.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

3.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

4.

Navigating the Complexities of Ph Negative ALL - Part IV

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot